Gene expression profiling and in vitro functional studies reveal RAD54L as a potential therapeutic target in multiple myeloma

CONCLUSIONS: This study has identified possible molecular targets underlying the pathogenesis of MM. For the first time, we reveal RAD54L as a potential therapeutic target in MM, possibly functioning in the cell cycle and checkpoint control.PMID:35689754 | DOI:10.1007/s13258-022-01272-7
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research